COMP <GO>
VTRS vs JNJ // 10Y YIELD & FRED MACRO BETA
Viatris Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: VTRS 3
— JNJ 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: VTRS
LAST: $19.04 (-0.83%) • MKT CAP: $22.05B
macro-sensitivity
1.15
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTRS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VTRS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.20% | 67.90% | -32.70 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.10% | 25.50% | -33.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.78% | 2.97% | +5.81 | VTRS | /fcf-yield <GO> |
| Operating Margin | -18.70% | 34.70% | -53.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -14.60% | 28.50% | -43.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 6.00% | -9.00 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.81 | 5.59 | -4.78 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 7.20% | +0.20 | JNJ | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 60.4 | +3.79 | VTRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.15 | 1.08 | +0.07 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 23.0x | +10.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.05B | $662.49B | -$640.44B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VTRS REV | JNJ REV | VTRS GROSS % | JNJ GROSS % | VTRS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.25B | $94.19B | 35.2% | 67.9% | $1.94B | $19.70B |
| FY 2024 | $14.69B | $88.82B | 38.3% | 69.1% | $1.98B | $19.84B |
| FY 2023 | $15.39B | $85.16B | 44.0% | 44.0% | $2.21B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTRS // BETA 1.15
JNJ // BETA 1.08